gabexate has been researched along with Blood Loss, Surgical in 1 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Blood Loss, Surgical: Loss of blood during a surgical procedure.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaku, R | 1 |
| Matsumi, M | 1 |
| Ichiyama, M | 1 |
| Kajihara, H | 1 |
| Fujii, H | 1 |
| Ohashi, I | 1 |
| Mizobuchi, S | 1 |
| Morita, K | 1 |
1 other study available for gabexate and Blood Loss, Surgical
| Article | Year |
|---|---|
[Massive bleeding due to hyperfibrinolysis during living-related liver transplantation for terminal liver cirrhosis; report of two cases].
Topics: Anticoagulants; Blood Loss, Surgical; Blood Transfusion; Fibrinolysis; Gabexate; Homeostasis; Humans | 2003 |